Literature DB >> 11859932

Selective loss of KGDHC-enriched neurons in Alzheimer temporal cortex: does mitochondrial variation contribute to selective vulnerability?

L W Ko1, K F Sheu, H T Thaler, W R Markesbery, J P Blass.   

Abstract

THE RESEARCH
OBJECTIVE: of this study was to test whether variation in mitochondrial composition is associated with "selective vulnerability" in Alzheimer brain. The term "selective vulnerability" refers to the loss of relatively vulnerable brain cells and the sparing of relatively resistant brain cells in disorders in which a genetic defect or environmental agent acts on both types of cells. The mechanisms underlying selective vulnerability are largely unknown, but mitochondria may be involved; the composition of mitochondria varies among different types of neurons, and mitochondria have an important role in cell death. Alzheimer's Disease (AD) is one of a number of neurodegenerative disorders in which both selective vulnerability and abnormalities of mitochondria occur.
METHODS: We examined by immunohistochemistry the cellular distribution of a mitochondrial constituent (the alpha-ketoglutarate dehydrogenase complex, KGDHC) known to be deficient in AD, in relation to the known selective vulnerability of neurons in areas 21 and 22 of the temporal lobe in this neurodegenerative disorder.
RESULTS: In normal human brain, cortical layers III and V contain neurons intensely immunoreactive for KGDHC, compared to other cells in these areas. The KGDHC-enriched cells are lost in AD (p < 0.001). In layer III, the loss of KGDHC-enriched cells is proportional to total loss of neurons, as determined by immunoreactivity to neuron specific enolase (NSE). In layer V, a higher proportion of the KGDHC-enriched neurons are lost than of other (NSE positive) neurons (p < 0.001). SIGNIFICANCE: Variations in mitochondrial composition may be one of the factors determining which cells die first when different types of cells are exposed to the same stress.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11859932     DOI: 10.1385/JMN:17:3:361

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  29 in total

Review 1.  Vulnerability of select neuronal types to Alzheimer's disease.

Authors:  H Braak; K Del Tredici; C Schultz; E Braak
Journal:  Ann N Y Acad Sci       Date:  2000       Impact factor: 5.691

2.  A DLST genotype associated with reduced risk for Alzheimer's disease.

Authors:  K F Sheu; A M Brown; B S Kristal; R N Kalaria; L Lilius; L Lannfelt; J P Blass
Journal:  Neurology       Date:  1999-04-22       Impact factor: 9.910

3.  Importance of neuroanatomy in the field of neuropathology.

Authors:  C VOGT; O VOGT
Journal:  Neurology       Date:  1951 May-Jun       Impact factor: 9.910

4.  Light microscopic immunocytochemical localization of pyruvate dehydrogenase complex in rat brain: topographical distribution and relation to cholinergic and catecholaminergic nuclei.

Authors:  T A Milner; C Aoki; K F Sheu; J P Blass; V M Pickel
Journal:  J Neurosci       Date:  1987-10       Impact factor: 6.167

Review 5.  Metabolic alterations common to neural and non-neural cells in Alzheimer's disease.

Authors:  J P Blass
Journal:  Hippocampus       Date:  1993       Impact factor: 3.899

6.  Distribution of the alpha-ketoglutarate dehydrogenase complex in rat brain.

Authors:  N Y Calingasan; H Baker; K F Sheu; G E Gibson
Journal:  J Comp Neurol       Date:  1994-08-15       Impact factor: 3.215

7.  Glucocorticoids potentiate ischemic injury to neurons: therapeutic implications.

Authors:  R M Sapolsky; W A Pulsinelli
Journal:  Science       Date:  1985-09-27       Impact factor: 47.728

Review 8.  Mitochondrial involvement in Parkinson's disease, Huntington's disease, hereditary spastic paraplegia and Friedreich's ataxia.

Authors:  A H Schapira
Journal:  Biochim Biophys Acta       Date:  1999-02-09

Review 9.  Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease.

Authors: 
Journal:  Neurobiol Aging       Date:  1997 Jul-Aug       Impact factor: 4.673

10.  Affected enzyme activities in Alzheimer's disease are sensitive to antemortem hypoxia.

Authors:  D Terwel; J Bothmer; E Wolf; F Meng; J Jolles
Journal:  J Neurol Sci       Date:  1998-11-26       Impact factor: 3.181

View more
  18 in total

Review 1.  Alpha-ketoglutarate dehydrogenase: a target and generator of oxidative stress.

Authors:  Laszlo Tretter; Vera Adam-Vizi
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2005-12-29       Impact factor: 6.237

Review 2.  A survey of oxidative paracatalytic reactions catalyzed by enzymes that generate carbanionic intermediates: implications for ROS production, cancer etiology, and neurodegenerative diseases.

Authors:  Victoria I Bunik; John V Schloss; John T Pinto; Natalia Dudareva; Arthur J L Cooper
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  2011

Review 3.  The metabolism hypothesis of Alzheimer's disease: from the concept of central insulin resistance and associated consequences to insulin therapy.

Authors:  Katrin Morgen; Lutz Frölich
Journal:  J Neural Transm (Vienna)       Date:  2015-02-12       Impact factor: 3.575

4.  Curative role of pantothenic acid in brain damage of gamma irradiated rats.

Authors:  Shedid Sm; Saada Hn; Eltahawy Na; Hammad As
Journal:  Indian J Clin Biochem       Date:  2017-08-07

5.  Behavioral impact of the regulation of the brain 2-oxoglutarate dehydrogenase complex by synthetic phosphonate analog of 2-oxoglutarate: implications into the role of the complex in neurodegenerative diseases.

Authors:  L Trofimova; M Lovat; A Groznaya; E Efimova; T Dunaeva; M Maslova; A Graf; V Bunik
Journal:  Int J Alzheimers Dis       Date:  2010-10-26

6.  Oligomeric and fibrillar species of beta-amyloid (A beta 42) both impair mitochondrial function in P301L tau transgenic mice.

Authors:  Anne Eckert; Susanne Hauptmann; Isabel Scherping; Jessica Meinhardt; Virginie Rhein; Stefan Dröse; Ulrich Brandt; Marcus Fändrich; Walter E Müller; Jürgen Götz
Journal:  J Mol Med (Berl)       Date:  2008-08-16       Impact factor: 4.599

7.  Analysis of the genes coding for subunit 10 and 15 of cytochrome c oxidase in Alzheimer's disease.

Authors:  Massimiliano Vitali; Eliana Venturelli; Daniela Galimberti; Luisa Benerini Gatta; Elio Scarpini; Dario Finazzi
Journal:  J Neural Transm (Vienna)       Date:  2009-10-14       Impact factor: 3.575

8.  Age-related deficiencies in complex I endogenous substrate availability and reserve capacity of complex IV in cortical neuron electron transport.

Authors:  Torrie T Jones; Gregory J Brewer
Journal:  Biochim Biophys Acta       Date:  2009-09-30

Review 9.  Enzyme-catalyzed side reactions with molecular oxygen may contribute to cell signaling and neurodegenerative diseases.

Authors:  Victoria I Bunik; John V Schloss; John T Pinto; Gary E Gibson; Arthur J L Cooper
Journal:  Neurochem Res       Date:  2007-03-07       Impact factor: 3.996

10.  OGDHL is a modifier of AKT-dependent signaling and NF-κB function.

Authors:  Tanusree Sen; Nilkantha Sen; Maartje G Noordhuis; Rajani Ravi; T-C Wu; Patrick K Ha; David Sidransky; Mohammad Obaidul Hoque
Journal:  PLoS One       Date:  2012-11-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.